FOLD icon

Amicus Therapeutics

280 hedge funds and large institutions have $2.53B invested in Amicus Therapeutics in 2025 Q1 according to their latest regulatory filings, with 39 funds opening new positions, 113 increasing their positions, 87 reducing their positions, and 41 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding in top 10

Funds holding in top 10:

less first-time investments, than exits

New positions opened: | Existing positions closed:

less ownership

Funds ownership:

2% less funds holding

Funds holding: 286280 (-6)

12% less capital invested

Capital invested by funds: $2.87B → $2.53B (-$349M)

36% less call options, than puts

Call options by funds: $3.21M | Put options by funds: $5.04M

Holders
280
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
5
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$3.21M
Puts
$5.04M
Net Calls
Net Calls Change

Top Buyers

1 +$24.4M
2 +$23.7M
3 +$20.2M
4
Bank of America
Bank of America
North Carolina
+$12.7M
5
Two Sigma Investments
Two Sigma Investments
New York
+$8.94M

Top Sellers

1 -$28.6M
2 -$22.7M
3 -$21.8M
4
JP Morgan Chase
JP Morgan Chase
New York
-$18.9M
5
State Street
State Street
Massachusetts
-$6.87M
Name Holding Trade Value Shares
Change
Change in
Stake
151
$441K
152
$412K
153
$412K
154
$403K
155
$400K
156
$397K
157
$371K
158
$349K
159
$348K
160
$347K
161
$346K
162
$344K
163
$317K
164
$305K
165
$305K
166
$291K
167
$290K
168
$289K
169
$275K
170
$273K
171
$250K
172
$246K
173
$241K
174
$233K
175
$231K